atorvastatin has been researched along with nobiletin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Gao, Z; Li, F; Qiu, P; Rakariyatham, K; Song, M; Wang, M; Wu, X; Xiao, H; Xu, F; Zheng, J | 1 |
| Li, F; Qiu, P; Song, M; Wang, M; Wang, Q; Wu, X; Xiao, H; Xu, F; Zheng, J | 1 |
2 other study(ies) available for atorvastatin and nobiletin
| Article | Year |
|---|---|
Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Atorvastatin; Azoxymethane; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Flavones; HT29 Cells; Humans; Male; Mice; Rats; Rats, Inbred F344 | 2017 |
A metabolite of nobiletin, 4'-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Atorvastatin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Flavones; G1 Phase Cell Cycle Checkpoints; HT29 Cells; Humans; Molecular Structure; Rats; Rats, Inbred F344 | 2018 |